Merck ESMO 2026
Biotech

ESMO: Merck exec unruffled by ‘unfortunate’ cancer vax data leak

Merck & Co.'s Shweta Jain told Fierce about her attitude to the high-profile data leak: “It is what it is.”
James Waldron Oct 24, 2026 6:24am
Eli Lilly Lilly

ESMO: Lilly ADC sees 79% ORR in competitive ovarian cancer space

Oct 24, 2026 2:30am
GSK ESMO

ESMO: GSK cancer R&D chief says data ‘reinforces belief’ in mo-rez

Oct 23, 2026 6:05pm
Gilead

Gilead to buy PepStar’s oral IL-23 drug for $1.3B upfront

Oct 23, 2026 11:20am
Boehringer Ingelheim booth at AACR 2026

ESMO: Boehringer builds case for late-phase rival to Imdelltra

Oct 23, 2026 10:30am
lightning

Bolt strikes Prana reverse merger alongside $120M financing

Oct 23, 2026 10:21am
More News

ESMO: Why Zentalis is already dreaming of launching WEE1 drug

Oct 23, 2026 10:15am

ESMO: Takeda’s $1B bet ‘absolutely’ pays off with ADC ph. 3 win

Oct 23, 2026 8:48am

GSK's Waterhouse tapped to helm struggling CSL—Chutes & Ladders

Oct 23, 2026 8:30am

BMS leads Pathos' $237M series E alongside Alzheimer's link-up

Oct 23, 2026 8:00am